TriSalus Life Sciences (TLSIW) Accumulated Expenses (2022 - 2025)
Historic Accumulated Expenses for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $6.8 million.
- TriSalus Life Sciences' Accumulated Expenses fell 1401.55% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 1401.55%. This contributed to the annual value of $7.4 million for FY2024, which is 3032.4% down from last year.
- As of Q3 2025, TriSalus Life Sciences' Accumulated Expenses stood at $6.8 million, which was down 1401.55% from $7.1 million recorded in Q2 2025.
- TriSalus Life Sciences' Accumulated Expenses' 5-year high stood at $11.4 million during Q1 2024, with a 5-year trough of $6.4 million in Q4 2022.
- Moreover, its 4-year median value for Accumulated Expenses was $7.6 million (2024), whereas its average is $8.2 million.
- As far as peak fluctuations go, TriSalus Life Sciences' Accumulated Expenses surged by 6553.24% in 2023, and later crashed by 3032.4% in 2024.
- Quarter analysis of 4 years shows TriSalus Life Sciences' Accumulated Expenses stood at $6.4 million in 2022, then surged by 65.53% to $10.6 million in 2023, then tumbled by 30.32% to $7.4 million in 2024, then dropped by 7.91% to $6.8 million in 2025.
- Its last three reported values are $6.8 million in Q3 2025, $7.1 million for Q2 2025, and $8.4 million during Q1 2025.